Cystic fibrosis-related diabetes

Diabetic Medicine

Volumn 20, Issue 6, 2003, Pages 425-436

  Mackie, A D R ^a   Thornton, S J ^a   Edenborough, F P ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Cystic fibrosis related diabetes; Insulin resistance; Insulin sensitivity; Microvascular complications; Type 1 diabetes; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PROINSULIN; SOMATOSTATIN;

AGE; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; KETOACIDOSIS; LIPID METABOLISM; LUNG DISEASE; LUNG INFECTION; LUNG TRANSPLANTATION; MORTALITY; NUTRITIONAL SUPPORT; ORAL GLUCOSE TOLERANCE TEST; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PROTEIN METABOLISM; REVIEW;

ADMINISTRATION, ORAL; BREAST FEEDING; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIETARY SUPPLEMENTS; FEMALE; GLUCAGON; GLUCOSE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; ISLETS OF LANGERHANS; LIPID METABOLISM; LUNG TRANSPLANTATION; NUTRITION PHYSIOLOGY; PREGNANCY; PREGNANCY IN DIABETICS; PROGNOSIS; PROTEINS;

EID: 0038798561     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00924.x     Document Type: Review

References (145)

1. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G et al. Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. Paediatr Perinat Epidemiol 1993; 7: 157-166.
2. Lewis PA. The epidemiology of cystic fibrosis. In Hodson ME, Geddes DM eds. Cystic Fibrosis. London: Chapman & Hall, 1995: 1-13.
3. Fanconi G, Uehlinger E, Knauer C. Das coeliakiesyndrom bei angeborener zysticher Pankreasfibromatose und Bronkiektasen. Wien Med Wochenschr 1936; 86: 753-756.
4. Landsteiner K. Darmverschluss durch eingedicktes Meconium. Pankreatitis. Zentrabl Allg Pathol 1905; 16: 903-907.
5. Garrod AE, Hurley WH. Congenital familial steatorrhoea. Q J Med 1912-1913; 6: 242-258.
6. Super M. Milestones in cystic fibrosis. Br Med Bull 1992; 48: 717-737.
7. Kerem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti V et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
8. Rommens JM, Ionuzzi MC, Kerem B-S, Drumm ML, Melmer G, Dean M et al. Identification of cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
9. Riordan RJ, Rommens JM, Kerem B-S, Aloz N, Rozmahel R, Grzelczak Z et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
10. Kerem E, Corey M, Kerem B, Rommens J, Markiewicz D, Levison H et al. The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (F508). N Engl J Med 1990; 323: 1517-1522.
11. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui L-C et al. Genetic determinants of exocrine pancreas function in cystic fibrosis. Am J Hum Genet 1992; 50: 1178-1184.
12. Koch C, Cuppens H, Rainiso M, Madessani U, Harms HK, Hodson ME et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Paediatr Pulmonol 2001; 31: 1-12.
13. Aitken ML, Fiel SB. Cystic fibrosis. Dis Mort 1993; 39: 1-52.
14. Hodson ME, Geddes DM eds. Cystic Fibrosis. London: Chapman & Hall, 1995.
15. Yankaskas JR, Knowles MR eds. Cystic Fibrosis in Adults. New York: Lippencott-Raven, 1999.
16. Anderson CM. Long-term study of patients with cystic fibrosis. Mod Probl Pediatr 1967; 10: 344-349.
17. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991; 46: 881-885.
18. Nir M, Lanng S, Johansen HK, Koch C. Long term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre. Thorax 1996; 51: 1023-1027.
19. Corey M. Modelling survival in cystic fibrosis. Thorax 2001; 56: 743.
20. Nielson OH, Schiøtz PO. Cystic fibrosis in Denmark in the period 1945-81. Evaluation of centralised treatment. Acta Paediatrica Scand Supplement 1982; 301: 107-119.
21. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 583-591.
22. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa infection by early treatment. Lancet 1991; 338: 725-726.
23. Fredericksen B, Lanng S, Koch C, Hoiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996; 21: 153-158.
24. Andersen DH. Cystic fibrosis in the pancreas and its relationship to celiac disease. Am J Dis Child 1938; 56: 344-399.
25. Shwachman H, Leubner H. Mucoviscidosis. Adv Paediatr 1955; 7: 249-322.
26. Rosan RC, Shwachman H, Kulczycki LL. Diabetes mellitus and cystic fibrosis of the pancreas. Am J Dis Child 1962; 104: 625-634.
27. Milner AD. Blood glucose and serum insulin levels in children with cystic fibrosis. Arch Dis Child 1969; 44: 351-355.
28. Handwerger S, Roth J, Gorden P, Di Sant'Agnese P, Carpenter DF, Peter G. Glucose intolerance in cystic fibrosis. N Engl J Med 1969; 281: 451-461.
29. Di Sant'Agnese PA, Davis PB. Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med 1979; 66: 121-132.
30. Robert JJ, Grasset E, De Montalembert M, Chevenne D, Deschamps I, Boitard C et al. Reserche de facteurs d'intolerance au glucose dans la muscoviscidose. Arch Fr Pediatr 1992; 49: 17-22.
31. Lanng S, Hansen A, Thorsteinnson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. Br Med J 1995; 311: 655-659.
32. De Luca F, Arrigo T, Nibali SC, Sferlazzas C, Gigante A, Di Cesare E et al. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res 1991; 23: 495-498.
33. Yung B, Hodson ME. Diabetes in cystic fibrosis. J R Soc Med 1999; 92: 35-40.
34. Charlton J, Liddle K, Innes A, McKnight J. Setting up a diabetes/cystic fibrosis service. Diabet Med 2001; 18: 100A.
35. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: a ten-year prospective study. Diabetologia 2000; 43: 107A.
36. Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum Genet 1994; 93: 364-368.
37. Finkelstein SM, Wielinski CL, Elliot GR, Warwick WJ, Barbosa J, Wu SC et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373-377.
38. Rosenecker J, Eichler I, Kühn L, Harms HK, von der Hardt H. Genetic determination of diabetes mellitus in patients with cystic fibrosis. J Pediatr 1995; 127: 441-443.
39. Cucinotta D, De Luca F, Scoglio R, Lombardo F, Sferlazzas C, Di Benedetto A et al. Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Pædiatr 1999; 88: 389-393.
40. Moran A, Doherty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998; 133: 10-17.
41. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993; 329: 1308-1313.
42. Hamdi I, Payne SJ, Barton DE, McMahon R, Green M, Shneerson JM et al. Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus. Clin Genet 1993; 43: 186-189.
43. Lanng S, Thorsteinsson B, Erichsen G, Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child 1991; 66: 612-616.
44. Cotellessa M, Mazzella M, Bruno C, Buzzanca C, Minicucci L, Gandino M et al. N1303K mutation and diabetes mellitus in cystic fibrosis. Arch Dis Child 1996; 75: 546.
45. Gan K-H, Veeze HJ, van den Ouweland AMW, Halley DJJ, Scheffer H, van der Hour A et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med 1995; 333: 95-99.
46. Stutchfield PR, O'Halloran SM, Smith CS, Woodrow JC, Bottazzo GF, Heaf D. HLA type, islet cell antibodies and glucose intolerance in cystic fibrosis. Arch Dis Child 1988; 63: 1234-1239.
47. Zanelli P, Neri TM, De Fanti A, Boselli E, Grzincich GL, Betterle C et al. Genetic and immunological markers of preclinic insulin dependent diabetes mellitus (IDDM) in cystic fibrosis (CF). Workshop of Cystic Fibrosis, Sestri Levante, Italy 1990.
48. Lanng S, Thorsteinsson B, Pociot F, Marshall MO, Madsen HO, Schwartz M et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Pædiatr 1993; 82: 150-154.
49. Cystic Fibrosis Foundation Patient Registry. Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation, 1998.
50. Rodman HM, Doershuk CF, Roland JM. The interaction of 2 diseases: diabetes mellitus associated with cystic fibrosis. Medicine 1986; 65: 389-397.
51. Reisman J, Corey M, Canny G, Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 1990; 86: 374-377.
52. Thornsteinsson B, Lanng S, Nerup J, Koch C. Epidemiology of glucose intolerance in cystic fibrosis. Diabetes 1991; 40: 320A.
53. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-687.
54. Cucinotta D, Arrigo T, De Luca F, Di Benedetto A, Lombardo F, Scoglio R et al. Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis. Eur J Endocrinol 1996; 134: 731-736.
55. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-895.
56. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Paediatr Pulmonol 2001; 32: 343-350.
57. Geffner ME, Lippe BM, Kaplan SA, Itami RM, Gillard BK, Levin SR et al. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function. Pediatric Res 1984; 18: 1107-1111.
58. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Pædiatr 1994; 83: 849-53.
59. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Ruff N et al. Cystic-fibrosis: impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867.
60. Green OC. Endocrinological complications associated with cystic fibrosis. In Lloyd-Still JD ed. Textbook of Cystic Fibrosis. Boston, MA: John Wright PSG Inc., 1983: 329-349.
61. Gorvoy JD. Cataracts, arterio-vascular calcifications, and retinopathy in a patient with cystic fibrosis and diabetes mellitus. In Cystic Fibrosis Club Abstracts. Twenty-Sixth Annual Meeting, Anaheim, California, 16-17 May 1985; 26: 178.
62. Dolan TF. Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med 1986; 314: 991-992.
63. Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998; 92: 871-872.
64. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiøtz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Pædiatr 1994; 83: 72-77.
65. Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989; 84: 642-647.
66. Oppenheimer EH. Glomerular lesions in cystic fibrosis: possible relation to diabetes mellitus, acquired cyanotic heart disease and cirrhosis of the liver. John Hopkins Med J 1972; 131: 351-366.
67. Allen J. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Eng J Med 1986; 315: 764.
68. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effects of high dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995; 332: 848-854.
69. Conway SP, Littlewood JM. Cystic Fibrosis in Children and Adults: The Leeds Method of Management. Leeds, UK: Leeds Teaching Hospitals Trust, 2000.
70. Abdul-Karim FW, Dahms BB, Velasco ME, Rodman HM. Islets of Langerhans in adolescents and adults with cystic fibrosis. Arch Pathol Lab Med 1986; 110: 602-606.
71. Löhr M, Goertchen P, Nizze H, Gould NS, Gould VE, Oberholzer M et al. Cystic fibrosis associated islet changes may provide a basis for diabetes: an immunocytological and morphometrical study. Virchows Arch A Pathol Anat 1989; 414: 179-185.
72. Iannucci A, Mukai K, Johnson D, Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984; 15: 278-284.
73. Soejima K, Landing BH. Pancreatic islets in older patients with cystic with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol 1986; 6: 25-46.
74. Klöppel G, Bommer G, Commandeur G, Heitz P. The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies. Virchows Arch Pathol Anat 1978; 377: 157-174.
75. Couce M, O'Brien TD, Moran A, Roche PC, Butler PC. Diabetes mellitus in cystic fibrosis is characterised by islet amyloidosis. JCEM 1996; 81: 1267-1272.
76. Matthews DR, Clark A. B-cell defects and pancreatic abnormalities in non-insulin-dependent diabetes mellitus. In Pickup JC, Williams G eds. Textbook of Diabetes. Oxford: Blackwell Science, 1997: 21.1-16.
77. Wilmhurst EG, Soeldner JS, Holsclaw DS, Kaufman RL, Shwachman H, Aoki TT et al. Endogenous and exogenous insulin response in patients with cystic fibrosis. Pediatrics 1975; 55: 75-82.
78. Hamdi I, Green M, Shneerson JM, Palmer CR, Hales CN. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Clin Endocrinol 1993; 39: 21-26.
79. Lanng S, Thorsteinsson B, Røder ME, Ørskov C, Holst JJ, Nerup J et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic patients with normal, impaired and diabetic glucose tolerance. Acta Endocrinol 1993; 128: 207-214.
80. Holl RW, Heinze E, Wolf A, Rank M, Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 1995; 154: 356-361.
81. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Paediatrics 1991; 118: 715-723.
82. Lanng S. Glucose intolerance in cystic fibrosis. Dan Med Bull 1997; 44: 23-39.
83. Lippe BM, Sperling MA, Dooley RR. Pancreatic alpha and beta cell function in cystic fibrosis. J Pediatr 1977; 90: 751-755.
84. Meacham LR, Caplan DB, McKean LP, Buchanan CN, Parks JS, Culler FL. Preservation of somatostatin secretion in cystic fibrosis patients with diabetes. Arch Dis Child 1993; 68: 123-125.
85. Stahl M, Girard J, Rutishauser M, Nars PW, Zuppinger K. Endocrine function of the pancreas in cystic fibrosis: evidence for an impaired glucagon and insulin response following arginine infusion. J Pediatr 1974; 84: 821-824.
86. Larsen S, Hilsted J, Tronier B, Worning H. Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function. Acta Endocrinol 1988; 118: 357-364.
87. Nousia-Arvanitakis S, Tomita T, Desai N, Kimmel JR. Pancreatic polypeptide in cystic fibrosis. Arch Pathol Lab Med 1985; 109: 722-726.
88. Mohan V, Alagappan V, Snehalatha C, Ramachandran A, Thiruvengada KV, Viswanathan M. Insulin and C-peptide responses to glucose load in cystic fibrosis. Diabet Metab 1985; 11: 376-379.
89. Andersen O, Garne S, Heilmann C, Petersen KE, Petersen J, Koch C. Glucose tolerance and insulin receptor binding to monocytes and erythrocytes in patients with cystic fibrosis. Acta Pædiatr Scand 1988; 77: 67-71.
90. Lanng S, Thorsteinsson B, Røder ME, Nerup J, Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis in patients with normal and diabetic glucose tolerance. Clin Endocrinol 1994; 41: 217-223.
91. Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994; 43: 163-167.
92. Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S. Roles of insulin resistance and β-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. JCEM 1994; 79: 80-85.
93. Cucinotta D, De Luca F, Gigante A, Arrigo T, Di Benedetto A, Tedeschi A et al. No changes in insulin sensitivity in cystic fibrosis with different degrees of glucose intolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994; 130: 253-258.
94. Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS et al. Insulin sensitivity in cystic fibrosis. Diabetes 1994; 43: 1020-1026.
95. Hardin DS, LeBlanc A, Lukenbaugh S, Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatrics 1997; 130: 948-956.
96. Hardin DS, LeBlanc A, Para L, Seilheimer DK. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 1999; 48: 1082-1087.
97. Zemel BS, Kawchak DA, Cnaan A, Zhao H, Scanlin TF, Stallings VA. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function and genotype in children with cystic fibrosis. Pediatr Res 1996; 40: 578-585.
98. Thomson MA, Wilmott RW, Wainwright C, Masters B, Francis PJ, Shepherd RW. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. J Pediatr 1996; 129: 367-373.
99. Holt TL, Ward LC, Francis PJ, Isles A, Cooksley WGE, Shepherd RW. Whole body protein turnover in malnourished cystic fibrosis patients and its relationship to pulmonary disease. Am J Clin Nutr 1985; 41: 1061-1066.
100. Moran A, Milla C, Ducret R, Nair KS. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 2001; 50: 1336-1343.
101. Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1998; 101: 433-437.
102. Shepherd RW, Holt TL, Thomas BJ, Kay J, Isles A, Francis PJ et al. Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease. J Pediatr 1986; 109: 788-794.
103. Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993; 76: 559-565.
104. Flatt JP. The biochemistry of energy expenditure. Rec Adv Obes Res 1978; 2: 211-228.
105. Hubbard VS, Dunn GD, Di Sant'Agnese PA. Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis: a primary or secondary defect? Lancet 1977; 2: 1302-1304.
106. Slesinski MJ, Gloninger MF, Costantino JP, Orenstein DM. Lipid levels in adults with cystic fibrosis. j Am Diet Assoc 1994; 94: 402-408.
107. Figuero V, Milla C, Parks EJ, Schwarzenberg SJ, Moran A. Abnormal lipid concentrations in cysfic fibrosis. Am J Clin Nutr 2002; 75: 1005-1011.
108. Stutchfield PR, O'Halloran S, Teale JD, Isherwood D, Smith CS, Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child 1987; 62: 805-810.
109. Hunkert F, Lietz T, Stach B, Kiess W. Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes. Diabetes Care 1999; 22: 1008-1009.
110. Allen HF, Gay EC, Klingensmith GJ, Hamman RF. Identification and treatment of cystic fibrosis-related diabetes: a survey of current medical practice in the U.S. Diabetes Care 1998; 21: 943-948.
111. Holl RW, Buck C, Cario H, Wolf A, Thon A, Kohne E et al. Diagnosis of diabetes in cystic fibrosis and thalassemia major. Diabetes Care 1998; 21: 671-672.
112. Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999; 54: 40-43.
113. Moran A. Highlights of the February 1998 consensus conference on CFRD. Paediatr Pulmonol 1998; Suppl. 17: 104-105.
114. Hardin DS, Moran A. Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin N Am 1999; 28: 787-800.
115. Cystic Fibrosis Foundation Conference on CF-Related Diabetes Mellitus, Tysons Corner, VA, 11-12 January 1990. Cystic Fibrosis Foundation Consensus Conferences, 1990; 1: 1-8.
116. Pirzada OM, Wales JKH. Cystic fibrosis and diabetes. Thorax 1999; 54: 751.
117. Dodge JA. Nutritional requirements in cystic fibrosis; a review. J Pediatr Gastroenterol Nutr 1988; 7: S8-S11.
118. Pencharz PB, Durie PR. Pathogenesis of malnutrition in cystic fibrosis and its rreatment. Clin Nutr 2000; 19: 387-394.
119. Ashworth FA, Bramwell EC, Yung B, Hodson ME. The management of cystic fibrosis related diabetes. Br J Homecare 1999; 1: 136-140.
120. Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64: 3-9.
121. Morison S, Dodge JA, Cole TJ, Lewis PA, Coles EC, Geddes D et al. (the UK Cystic Fibrosis Survey Management Committee). Height and weight in cystic fibrosis: a cross sectional study. Arch Dis Child 1997; 77: 497-500.
122. Rettammel AL, Marcus MS, Farrell PM, Sandel SA, Koscik RE, Mischler EH. Oral supplementation with high fat, high energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis. J Am Diet Assoc 1995; 95: 454-459.
123. Milla C, Doherty L, Raatz S, Schwarzenberger SJ, Regelmann W, Moran A. Glycaemic response to dietary supplements in cystic fibrosis is dependant on the carbohydrate content of the formula. J Parent Ent Nutr 1996; 20: 182-186.
124. Skypala IJ, Ashworth FA, Hodson ME, Leonard CH, Knox A, Hiller EJ et al. Oral supplements promote significant weight gain in cystic fibrosis patients. J Hum Nutr Diet 1998; 11: 95-104.
125. Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr 1994; 124: 244-249.
126. Kane RE, Black P. Glucose intolerance with low-, medium- and high-carbohydrate formulas during night time enteral feedings in cystic fibrosis patients. J Paed Gast Nutr 1989; 8: 321-326.
127. Erskine JM, Lingard CD, Sontag MK, Accurso FJ. Enteral nutrition for patients with cystic fibrosis: comparison of a semielemental and nonelemental formula. J Pediatr 1998; 132: 265-269.
128. Williams SGJ, Ashworth F, McAlweenie A, Poole S, Hodson ME, Westaby D. Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut 1999; 44: 87-90.
129. Wilson DC, Kalnins D, Stewart C, Hamilton N, Hanna AK, Durie PR et al. Challenges in the dietary treatment of cystic fibrosis related diabetes mellitus. Clin Nutr 2000; 19: 87-93.
130. Lester LA, Rothberg RM, Dawson G, Lopez AL, Corpus Z. Supplemental parenteral nutrition in cystic fibrosis. J Parenteral Enteral Nutr 1986; 10: 289-295.
131. Ramsey BW, Farrell PM, Pencharz P and the Consensus Committee. Nutritional assessment and management in CF: a consensus report. Am J Clin Nutr 1992; 55: 108-116.
132. Yacoub MY, Banner HR, Khaghani A, Fitzgerald M, Madden B, Tsang V et al. Heart-lung transplant for cystic fibrosis and subsequent domino heart transplant. J Heart Transpl 1990; 9: 459-467.
133. Ramirez JC, Patterson GA, Winton TL, de Hoyos AL, Miller JD, Mauser JR et al. Bilateral lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1992; 103: 287-294.
134. Aurora P, Balfour-Lynn IM. Lung transplantation and end of life issues in cystic fibrosis. Paed Resp Rev 2000; 1: 114-120.
135. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJS et al. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001; 56: 746-750.
136. Tschopp J-M, Brutsche MH, Frey J-G, Spiliopoulos A, Nicod L, Rochat T et al. End-stage cystic fibrosis: improved diabetes control 2 years after successful isolated pancreatic cell and double-lung transplantation. Chest 1997; 112: 1685-1687.
137. Cretin N, Bühler L, Fournier B, Caulfield A, Oberholzer J, Becker C et al. Results of human islet allotransplantation in cystic fibrosis and type I diabetes mellitus. Transplant Proc 1998; 30: 315-316.
138. Kent NE, Farquharson DF. Cystic fibrosis and pregnancy. Can Med Assoc J 1993; 149: 809-813.
139. Edenborough FP, Mackenzie WE, Stableforth DE. The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977-1996. Br J Obs Gyn 2000; 107: 254-261.
140. Luder E, Kattan M, Tanzer-Torres G, Bonforte RJ. Current recommendations for breast feeding in cystic fibrosis centres. Am J Dis Child 1990; 144: 1153-1156.
141. FitzSimmons SC, Fitzpatrick S, Thompson B, Aitkin M, Fiel S, Winnie G et al. A longitudinal study of the effects of pregnancy on 325 women with cystic fibrosis. Pediatr Pulmonol Suppl 1996; 13: 99-101.
142. McFadyen IR. Maternal physiology in pregnancy. In Chamberlain G ed. Turnbull's Obstetrics, 2nd edn. London: Churchill Livingstone, 1995: 115-141.
143. Zipf W. Therapeutic options for treatment of diabetes mellitus in cystic fibrosis. Paediatr Pulmonol Suppl 1995; 5: 111-114.
144. Rosenecker J, Eichler I, Bärmeier H, von der Hardt H. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001; 32: 351-355.
145. Lanng S.Glucose intolerance in cystic fibrosis patients. Paediatr Resp Rev 2001; 2: 253-259.